CMS is proposing major reforms to Medicare Advantage Star Ratings to address administrative measure concerns raised in industry lawsuits. These changes could impact plan quality assessments and compliance.
Explore recent US developments on federal drug price negotiation expansion to commercial plans, DEA telehealth prescribing extensions, the 340B rebate pilot launch, and ACA subsidy debates in the Senate impacting insurance and healthcare markets.
GAO report uncovers extensive fraud in ACA marketplace with fake identities approved for subsidies, highlighting regulatory challenges as premium subsidies face congressional debate.
Insightful analysis of the WISeR pilot program's implications on Medicare prior authorization processes, healthcare fraud prevention, and impact on beneficiaries.
CMS proposes major changes to Medicare Advantage Star Ratings, removing administrative measures and focusing on patient outcomes with mixed reactions from healthcare stakeholders.
CMS warns Minnesota Governor Tim Walz about potential federal Medicaid funding cuts arising from a $1 billion fraud scheme involving Medicaid programs and allegations of funds supporting terrorist activity.
CMS Administrator Mehmet Oz warns Minnesota Governor Tim Walz about over $1 billion in alleged Medicaid fraud risking federal funding. CMS demands corrective measures to restore Medicaid program integrity.
CMS Administrator Dr. Mehmet Oz visits Hudson Valley, NY, for discussions on strengthening Medicare and Medicaid, addressing workforce shortages, and improving healthcare access and affordability.
CMS Administrator Dr. Mehmet Oz visited New York's Hudson Valley to discuss Medicare and Medicaid service improvements with healthcare leaders and Congressman Mike Lawler, focusing on workforce shortages, cost reduction, and access.
The 2026 Medicare Advantage market confronts challenges from regulatory changes, insurer profitability strategies, and shifts in beneficiary enrollment impacting healthcare access and market dynamics.
